5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early versus delayed initiation of salvage androgen deprivation therapy and risk of prostate cancer-specific mortality
    Journal Article

    Mahal, B. A.; Chen, M. H.; Renshaw, A. A.; Loffredo, M. J.; Kantoff, P. W.; D'Amico, A. V.
    Journal of the National Comprehensive Cancer Network (2018)

    Fulltext@MSK | Save
  • Pazopanib exposure relationship with clinical efficacy and safety in the adjuvant treatment of advanced renal cell carcinoma
    Journal Article

    Sternberg, C. N.; Donskov, F.; Haas, N. B.; Doehn, C.; Russo, P.; Elmeliegy, M.; Baneyx, G.; Banerjee, H.; Aimone, P.; Motzer, R. J.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Unilateral upper extremity lymphedema in metastatic prostate cancer
    Journal Article

    Mupamombe, C. T.; LoGiurato, B.; Kampel, L.; Cohen, J. M.
    Clinical Case Reports (2018)

    Fulltext@MSK | Save
  • Concurrent alterations in EGFR-mutant lung cancers associated with resistance to EGFR kinase inhibitors and characterization of MTOR as a mediator of resistance
    Journal Article

    Yu, H. A.; Suzawa, K.; Jordan, E.; Zehir, A.; Ni, A.; Kim, R.; Kris, M. G.; Hellmann, M. D.; Li, B. T.; Somwar, R.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Efficacy of BGJ398, a fibroblast growth factor receptor 1-3 inhibitor, in patients with previously treated advanced urothelial carcinoma with FGFR3 alterations
    Journal Article

    Pal, S. K.; Rosenberg, J. E.; Hoffman-Censits, J. H.; Berger, R.; Quinn, D. I.; Galsky, M. D.; Wolf, J.; Dittrich, C.; Keam, B.; Delord, J. P.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Optimizing anticancer therapy in metastatic non-castrate prostate cancer: ASCO clinical practice guideline summary
    Journal Article

    Morris, M. J.; Rumble, R. B.; Milowsky, M. I.
    Journal of Oncology Practice (2018)

    Fulltext@MSK | Save
  • Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1/PD-L1 blockade in advanced urothelial cancers
    Journal Article

    Teo, M. Y.; Seier, K.; Ostrovnaya, I.; Regazzi, A. M.; Kania, B. E.; Moran, M. M.; Cipolla, C. K.; Bluth, M. J.; Chaim, J.; Al-Ahmadie, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Health-related quality-of-life analysis from KEYNOTE-045: A phase III study of pembrolizumab versus chemotherapy for previously treated advanced urothelial cancer
    Journal Article

    Vaughn, D. J.; Bellmunt, J.; Fradet, Y.; Lee, J. L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; Choueiri, T. K.; Necchi, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Update on tumor neoantigens and their utility: Why it is good to be different
    Journal Article

    Lee, C. H.; Yelensky, R.; Jooss, K.; Chan, T. A.
    Trends in Immunology (2018)

    Fulltext@MSK | Save
  • Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group
    Journal Article

    Miyahira, A. K.; Pienta, K. J.; Morris, M. J.; Bander, N. H.; Baum, R. P.; Fendler, W. P.; Goeckeler, W.; Gorin, M. A.; Hennekes, H.; Pomper, M. G.; more...
    Prostate (2018)

    Fulltext@MSK | Save